NO20020604D0 - Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning - Google Patents

Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning

Info

Publication number
NO20020604D0
NO20020604D0 NO20020604A NO20020604A NO20020604D0 NO 20020604 D0 NO20020604 D0 NO 20020604D0 NO 20020604 A NO20020604 A NO 20020604A NO 20020604 A NO20020604 A NO 20020604A NO 20020604 D0 NO20020604 D0 NO 20020604D0
Authority
NO
Norway
Prior art keywords
therapeutic agents
delivering therapeutic
dextrin solution
dextrin
solution
Prior art date
Application number
NO20020604A
Other languages
English (en)
Other versions
NO20020604L (no
Inventor
Susan Conroy
Robert Nichol Boyes
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918785.8A external-priority patent/GB9918785D0/en
Priority claimed from US09/482,794 external-priority patent/US20030039960A1/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of NO20020604D0 publication Critical patent/NO20020604D0/no
Publication of NO20020604L publication Critical patent/NO20020604L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO20020604A 1999-08-10 2002-02-07 Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning NO20020604L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918785.8A GB9918785D0 (en) 1999-08-10 1999-08-10 Therapeutic treatment
GBGB9924980.7A GB9924980D0 (en) 1999-08-10 1999-10-22 Therapeutic treatment
US09/482,794 US20030039960A1 (en) 2000-01-13 2000-01-13 Therapeutic treatment
PCT/GB2000/003025 WO2001012231A1 (en) 1999-08-10 2000-08-09 Method for delivery of therapeutic agents using a solution of dextrin

Publications (2)

Publication Number Publication Date
NO20020604D0 true NO20020604D0 (no) 2002-02-07
NO20020604L NO20020604L (no) 2002-02-07

Family

ID=27269789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020604A NO20020604L (no) 1999-08-10 2002-02-07 Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning

Country Status (12)

Country Link
EP (1) EP1206284B1 (no)
JP (1) JP2003507345A (no)
AT (1) ATE366587T1 (no)
AU (1) AU779579B2 (no)
CA (1) CA2378708A1 (no)
DE (1) DE60035504D1 (no)
IL (1) IL147500A0 (no)
MX (1) MXPA02001472A (no)
NO (1) NO20020604L (no)
NZ (1) NZ516777A (no)
PL (1) PL353232A1 (no)
WO (1) WO2001012231A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001226926A1 (en) 2000-01-21 2001-07-31 M.L. Laboratories Plc Dextrin containing compositions for prevention of adhesions
US20020081736A1 (en) 2000-11-03 2002-06-27 Conroy Susan E. Nucleic acid delivery
MXPA03003983A (es) * 2000-11-03 2003-08-19 Ml Lab Plc Formulaciones que comprenden polimeros de dextrina en combinacion con azucares para la administracion de acidos nucleicos.
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
GB8714378D0 (en) * 1987-06-19 1987-07-22 Hunchplan Ltd Parenteral delivery of drugs
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6667293B1 (en) * 1995-09-12 2003-12-23 Hybridon, Inc. Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response

Also Published As

Publication number Publication date
PL353232A1 (en) 2003-11-03
WO2001012231A1 (en) 2001-02-22
AU779579B2 (en) 2005-01-27
AU6456500A (en) 2001-03-13
MXPA02001472A (es) 2002-07-02
DE60035504D1 (de) 2007-08-23
EP1206284B1 (en) 2007-07-11
ATE366587T1 (de) 2007-08-15
JP2003507345A (ja) 2003-02-25
EP1206284A1 (en) 2002-05-22
NZ516777A (en) 2004-12-24
NO20020604L (no) 2002-02-07
CA2378708A1 (en) 2001-02-22
IL147500A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
HUP0300246A2 (en) Delivery system
DE69837613D1 (de) J-kette und analoge für konjugate zielgerichtet auf epithelzellen
MY124214A (en) Compositions for promoting crowth
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
ATE273320T1 (de) Fusogene liposomen
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
DK0868505T3 (da) Chondrogen in vitro induktion af humane mesenchymstamceller
HK1049438A1 (en) Sub-tenon drug delivery.
ATE302040T1 (de) Ringstent
EP1183068A4 (en) ENHANCED ACTIVE AGENT DELIVERY METHOD BY ELECTROPORATION
ES2155817T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo.
EP1487493A4 (en) CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOACTIVE PEPTIDES
EP1154734A4 (en) INJECTABLE COLLAGEN COMPLEX FOR CARRYING OUT CELLS OR THERAPEUTIC ACTIVE SUBSTANCES
JO2178B1 (en) Treatment of invasive diseases, using selected anti-PAR materials
WO1998030709A3 (en) Non-immunogenic prodrugs and selectable markers for use in gene therapy
CR6683A (es) Sistema de entrega de quelator de hierro
NO20020604L (no) Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning
WO2003106640A3 (en) CELL TARGETING METHODS AND COMPOSITIONS
EP1295611A4 (en) COMPOUNDS FOR THE TRANSFER OF OLIGONUCLEOTIDES (03.01.02)
PT1007717E (pt) Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
EP1173192A4 (en) METHOD AND COMPOSITIONS FOR TARGETED MEDICINE ADMINISTRATION
GB9811221D0 (en) Bacterial-pheromones and uses therefor
HK1029919A1 (en) Method for preventing the misuse of a transdermal therapeutic system

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application